IP Review

Unattributed Code Systems

Copyright Fragment

This fragment is not visible to the reader

This publication includes IP covered under the following statements.

This material contains content from LOINC . LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license . LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
Show Usage
- LOINC: DiagnosticReport/HIEDiagnosticReport-example , DocumentReference/HIEDocumentReference-example , HIEDocumentReference , Observation/ExampleKenyaObservation and ServiceRequest/HIEServiceRequest-example
This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org .
Show Usage
- SNOMED Clinical Terms® (SNOMED CT®) : AllergyIntolerance/HIEAllergyIntolerance-example , Appointment/HIEAppointment-example ... Show 11 more
This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Show Usage

Copyright and Registered Trademark Uses

IG © 2025+ Kathurima Kimathi. Package hie-fhir-ig-profile#0.1.0 based on FHIR 4.3.0. Generated 2025-11-25 Links: Table of Contents | QA Report ( src )
hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide ®© HL7 | CC0 ( src )
SIL HIE Implementation Guide, published by Kathurima Kimathi. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/savannahghi/hie-fhir-ig-profile/ and changes regularly. See the Directory of published versions ( src )
There are examples where a medication request may include the option of an oral dose or an Intravenous or Intramuscular dose. For example, "Ondansetron 8mg orally or IV twice a day as needed for nausea" or "Compazine® (prochlorperazine) 5-10mg PO or 25mg PR bid prn nausea or vomiting". In these cases, two medication requests would be created that could be grouped together. The decision on which dose and route of administration to use is based on the patient's condition at the time the dose is needed. ( src )

External References

Type

Reference

Content

web

tel:+254717355900

telecom : +254717355900

web

github.com

SIL HIE Implementation Guide, published by Kathurima Kimathi. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/savannahghi/hie-fhir-ig-profile/ and changes regularly. See the Directory of published versions

web

www.linkedin.com

IG © 2025+ Kathurima Kimathi . Package hie-fhir-ig-profile#0.1.0 based on FHIR 4.3.0 . Generated 2025-11-25
Links: Table of Contents | QA Report

web

github.com

Repository: SIL FHIR Profile Implementation Guide GitHub

Internal Images

tree-filter.png